About Dylan Smith

This author has not yet filled in any details.
So far Dylan Smith has created 61 blog entries.

Understanding CMS Guidelines: Advanced Beneficiary Notices, Frequency Limitations & Non-Covered Tests

The Centers for Medicare & Medicaid Services (CMS) hold well-established guidelines regarding what is considered medically necessary within the realm of testing. Medical necessity is important in clinical testing because tests deemed to fall out of the definition of being medically necessary can end up being denied by CMS for reimbursement. As well, CMS has

By |2018-06-26T12:54:11-04:00June 26th, 2018|Categories: News|0 Comments

The Cobas 8000 Modular Analyzer helps to streamline lab workflow like never before

A laboratory not only needs its staff to be highly trained to run effectively, but it also requires state-of-the-art and cutting-edge equipment. Top-tier equipment can be the difference between disorganized and slow production versus a seamless and streamlined workflow. Roche Diagnostics, as a research and medical diagnostic applications manufacturer, brings such equipment to labs in

By |2018-06-21T16:12:25-04:00May 16th, 2018|Categories: News|0 Comments

Letter from the Director: Understanding the H1N1 Virus

Originally published in LabTalk (Volume 4, Issue 3, 2009), the quarterly newsletter of Aculabs. Novel H1N1 virus, known to be an influenza A-subtype, was originally referred to as “swine flu” because it is very similar to influenza viruses normally occurring in North American pigs (swine). Flu viruses are mainly spread from person to person through

By |2018-09-19T12:14:19-04:00September 30th, 2009|Categories: Quarterly Letter|0 Comments

Letter from the Director: Accurate Diagnosis Benefits of 25-Hydroxyvitamin D

Originally published in LabTalk (Volume 4, Issue 2, 2009), the quarterly newsletter of Aculabs. Vitamin D has been well known for its role in bone metabolism; however, the important role of vitamin D beyond that was the discovery of the 1,25-Dihydroxyvitamin D nuclear receptor in most tissue. Increased interest in vitamin D introduced the recent

By |2018-07-26T15:56:37-04:00June 30th, 2009|Categories: Quarterly Letter|0 Comments

Letter from the Director: High Sensitivity C-Reactive Protein & Statin Treatments

Originally published in LabTalk (Volume 4, Issue 1, 2009), the quarterly newsletter of Aculabs. JUPITER (Justification for the Use of Statins in Primary Prevention: an Intervention Trial Evaluating Rosuvastatin), a study published in the Nov. 20 edition of New England Journal of Medicine, showed that treatment with Statin could significantly reduce cardiovascular problems in apparently

By |2018-09-19T12:11:01-04:00January 31st, 2009|Categories: Quarterly Letter|0 Comments

Letter from the Director: Prostate Cancer Awareness & Diagnosis

Originally published in LabTalk (Volume 3, Issue 4, 2008), the quarterly newsletter of Aculabs. September was “National Prostate Cancer Awareness Month.” The goal of this annual event is to generate widespread awareness regarding prostate cancer and to give the public an opportunity to learn more about it and how to reduce their risk. Prostate cancer

By |2018-07-26T15:57:02-04:00December 31st, 2008|Categories: Quarterly Letter|0 Comments

Letter from the Director: Prothrombin Time Tests & Blood Clotting

Originally published in LabTalk (Volume 3, Issue 3, 2008), the quarterly newsletter of Aculabs. Prothrombin time (PT) tests measure clotting time in a blood sample from the activation of factor VII through the formation of fibrin clot. PT evaluates the integrity of the extrinsic and common pathways of coagulation. It is measured in seconds and

By |2018-07-26T15:57:14-04:00September 30th, 2008|Categories: Quarterly Letter|0 Comments

Letter from the Director: Urinary Tract Infection in Geriatric Populations

Originally published in LabTalk (Volume 3, Issue 2, 2008), the quarterly newsletter of Aculabs. Background Since UTI is very common among the geriatric population and can cause serious complications, urinalysis and urine cultures contribute vital information regarding a patient’s state of health and acts as a guide in the physician’s clinical decision regarding treatment. Evaluation

By |2018-07-26T15:57:16-04:00June 30th, 2008|Categories: Quarterly Letter|0 Comments

Letter from the Director: Thyroid Dysfunction

Originally published in LabTalk (Volume 2, Issue 4, 2007), the quarterly newsletter of Aculabs. Thyroid dysfunction is one of the most encountered problems in clinical practice. Adequate diagnosis and management require a thorough knowledge of the change in the thyroid function with age, and the effect of the Non-Thyroidal Illness (NTI) on laboratory results. Many

By |2018-07-26T15:55:59-04:00December 31st, 2007|Categories: Quarterly Letter|0 Comments
Go to Top